Immune Design Corp.
Pharmaceutical company · Seattle, Washington, United States
Immune Design Corp. is a pharmaceutical company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2008. It has reported private securities offerings to the US SEC, most recently $17,500 sold in a notice filed in 2014.
Immune Design at a glance
What does Immune Design do?
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $17,500 sold (2014).
Frequently asked questions about Immune Design
Where is Immune Design headquartered?
Immune Design Corp. is headquartered in Seattle, Washington, United States.
What does Immune Design do?
Immune Design Corp. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Immune Design founded?
The earliest incorporation on record for Immune Design Corp. is in 2008, according to public company registers.
Similar companies
- Omeros CorpSeattle, Washington, United States
- Chinook Therapeutics, Inc.Seattle, Washington, United States
- Cti Biopharma CorpSeattle, Washington, United States
- Perspective Therapeutics, Inc.Seattle, Washington, United States
- Aptevo Therapeutics Inc.Seattle, Washington, United States
- IPI Legacy Liquidation CoSeattle, Washington, United States
- Atossa Therapeutics, Inc.Seattle, Washington, United States
- Alpine Immune Sciences, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences